Cancer Immunotherapy Using Chimeric Antigen Receptor Expressing T-Cells: Present and Future Needs of Clinical Cancer Centers

Chimeric Antigen Receptor-T cells (CAR-T) are considered novel biological agents, designed to selectively attack cancer cells expressing specific antigens, with demonstrated clinical activity in patients affected with relapsed/refractory B-cell malignancies. In consideration of their complexity, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Gotti, Manuel, Defrancesco, Irene, D’Angelo, Mario, Basso, Sabrina, Crotto, Luca, Marinelli, Alfredo, Maccalli, Cristina, Iaconianni, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662555/
https://www.ncbi.nlm.nih.gov/pubmed/33193333
http://dx.doi.org/10.3389/fimmu.2020.565236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662555/
https://www.ncbi.nlm.nih.gov/pubmed/33193333
http://dx.doi.org/10.3389/fimmu.2020.565236

Ejemplares similares